Firocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary Firocoxib

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 130/g
Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
OEM Services
The supplier provides OEM services for popular brands
R&D Capabilities
The supplier has 1 R&D engineers, you can check the Audit Report for more information
to see all verified strength labels (13)
  • Firocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary Firocoxib
  • Firocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary Firocoxib
  • Firocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary Firocoxib
  • Firocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary Firocoxib
  • Firocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary Firocoxib
  • Firocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary Firocoxib
Find Similar Products
  • Overview
  • Product Description
Overview

Basic Info.

Certification
GMP, ISO 9001, USP
Suitable for
Adult
State
Powder
Purity
>99%
Sample
Available
OEM
Available
MOQ
1kg
CAS
189954-96-9
Keyword
Firocoxib
Keyword 1
Firocoxib Powder
Transport Package
1kg Foil Bag /25kg Drum
Specification
99%
Trademark
/
Origin
China
Production Capacity
20000

Product Description

Firocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary Firocoxib
Product Description

Description

Firocoxib(ML 1785713) is a potent and selective cyclooxygenase (COX)-2 inhibitor with IC50 of 0.13 uM, 58 fold sensitivity for COX2 VSCOX1.IC50 value: 0.13 uMTarget: COX2 inhibitorin vitro: Blood concentrations resulting in 50% inhibition of COX-1 and COX-2 activity in vitro were 75 +/- 2 microM and 0.13 +/- 0.03 microM, respectively, and selectivity for inhibiting COX-2 relative to COX-1 was 58. Firocoxib had moderate to high oral bioavailability (54% to 70%), low plasma clearance (4.7 to 5.8 mL/min/kg), and an elimination half-life of 8.7 to 12.2 hours. in vivo: Administration of firocoxib did not cause any adverse effects on GI, or hematological or serum biochemical variables and appears to have been well tolerated by dogs. Firocoxib (0.5 mg/kg) was initially administered i.v. to calves, and following a 14-day washout period, animals received firocoxib orally prior to cautery dehorning. Firocoxib concentrations were determined by liquid chromatography-tandem mass spectrometry. Firocoxib 5 mg/kg was given orally once daily for 180 days to five dogs with clinical signs and histopathological lesions consistent with solar dermatitis/actinic keratosis. On days 0, 50 and 180, the severity of erythema, skin shine, induration and the number of comedones were evaluated by a clinical scoring system.

Product name Firocoxib
Appearance white Powder
Specification 99%
Shelf life 2 years when properly stored

Function and Application

 1. Used for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs.
 2. Used for the control of pain and inflammation associated with osteoarthritis.

Firocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary FirocoxibFirocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary FirocoxibFirocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary FirocoxibFirocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary FirocoxibFirocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary FirocoxibFirocoxib Powder CAS 189954-96-9 Firocoxib Powder Veterinary Firocoxib

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier